A NEW PARTNERSHIP FOR EQUINE MEDICINE BETWEEN PFIZER ANIMAL HEALTH AND THE HIPPOLIA FOUNDATION
Dozulé, Normandy, France, 27 January 2012 – Pfizer Animal Health and The Hippolia Foundation announced today the formation of a strategic partnership to advance equine health through research and educational programmes.
The Hippolia Foundation – a network of leading French equine institutions together with international partners – will collaborate with Pfizer to accelerate advancement in innovation on the diagnosis, treatment and prevention of equine disease. The Hippolia partner organisations and Pfizer are initially investing more than $5 million over three years.
“This is an excellent example of a public/private initiative to advance our scientific knowledge and improve animal health and welfare,” said Pierre Lekeux, President, The Hippolia Foundation.
The two principal areas of collaboration to be developed between Pfizer and The Hippolia Foundation will focus on respiratory disorders, and on infectious diseases.
“This is a particularly synergistic partnership,” said Alejandro Bernal, Area President, Pfizer Animal Health, Europe, Africa and Middle East.
“Together, The Hippolia Foundation and Pfizer have created a partnership based on what is today the largest equine research network worldwide. Both parties will benefit from the combined expertise and resources in the interests of accelerating pioneering equine research.”
Pfizer Animal Health has a broad and leading portfolio of parasiticides, pharmaceuticals, and core and speciality vaccines. The latter group includes Equip for Flu, Tetanus and EHV as well as vaccines which address emerging disease - importantly, West Nile virus.
In November 2011, the company opened a new global Equine Research Center at its worldwide veterinary medicine research and development headquarters in greater Kalamazoo, Michigan. Pfizer Animal Health is dedicated to providing comprehensive solutions for equine health, including an integrated offer of vaccines, therapeutics, diagnostics, practice management and services.
Founded in 2011 and located in Normandy - at the centre of one of Europe’s most recognised regions for competition horses - The Hippolia Foundation supports and promotes the development of research programmes, training and services at an international level, particularly on issues of health, welfare and performance in horses.
The Normandy site has established a reputation as a world-class facility undertaking leading-edge research on racehorses (thoroughbred and standardbred) but also on sport horses. The Hippolia Foundation also has existing partnerships with hospitals, and it is expected that its research could possibly have comparative translational aspects that would benefit human health as well as equine.
About The Hippolia Foundation
The nine founding members of The Hippolia Foundation are:
- Agence Nationale de Sécurité Sanitaire de l’alimentation, l’environment et du travail (ANSES)
- Association Vétérinaire Equine Française (AVEF)
- Ecole Nationale Vétérinaire d’Alfort (ENVA)
- Institut Française du Cheval et de l’Equitation (IFCE)
- Institut National de la Recherche Agronomique (INRA)
- Pole de Compétitivité Filière Equine (PCFE)
- Syndicat de l’Industrie du Médicament Vétérinaire (SIMV)
- Université de Caen Basse-Normandie (UCBN)
- Université de Liège (Ulg)
About Pfizer Animal Health
Pfizer Animal Health, a business unit of Pfizer Inc, is a world leader in the discovery, development and manufacture of innovative animal health vaccines, medicines, and diagnostic products. Pfizer Animal Health invests more in research and development than any other animal health company. We work to assure a safe, sustainable global food supply from healthy beef and dairy cattle, swine, poultry and fish while helping dogs, cats and horses live healthier longer lives. We strive to be the animal health company that provides full healthcare solutions to veterinarians, livestock producers, and pet owners. To learn more, visit www.pfizeranimalhealth.com.
Issued by: Pfizer Animal Health
For further press information contact:
Elinore White Rebecca Lambert
Pfizer Animal Health Pfizer Animal Health